| Literature DB >> 25994290 |
Marie F Mutryn1, Erin M Brannick1, Weixuan Fu1, William R Lee2, Behnam Abasht3.
Abstract
BACKGROUND: Improvements in poultry production within the past 50 years have led to increased muscle yield and growth rate, which may be contributing to an increased rate and development of new muscle disorders in chickens. Previously reported muscle disorders and conditions are generally associated with poor meat quality traits and have a significant negative economic impact on the poultry industry. Recently, a novel myopathy phenotype has emerged which is characterized by palpably "hard" or tough breast muscle. The objective of this study is to identify the underlying biological mechanisms that contribute to this emerging muscle disorder colloquially referred to as "Wooden Breast", through the use of RNA-sequencing technology.Entities:
Mesh:
Year: 2015 PMID: 25994290 PMCID: PMC4438523 DOI: 10.1186/s12864-015-1623-0
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Heatmap gene cluster classification for Wooden Breast and unaffected muscle samples. Using the expression for each gene (in rows) and sample (in columns), the heatmap is generated by the R package “plots”. The expression levels of each gene across samples are shown as Z-scores scaled by their FPKM from RNA-seq. The scaled expression values are color-coded according to the legend. The dendrogram depicting hierarchical clustering is based on the expression of all genes
Top ten upregulated and downregulated genes with fold change for Wooden Breast myopathy-affected birds
| Gene | Description | RNA-seq fold change | Nanostring fold change |
|---|---|---|---|
| ENSGAL00000009603 | Prolactin-like protein precursor | 43.9 | N/A |
| CA3 | Carbonic anhydrase III | 28.5 | 25.5 |
| CLEC3A | C-type lectin domain family 3, A | 25.3 | N/A |
| KPNA7 | Karyopherin alpha 7 | 24.4 | 8.0 |
| CSRP3 | Cysteine and glycine-rich protein 3 | 23.2 | 27.3 |
| CRISP1 | Cysteine-rich secretory protein 1 | 21.5 | N/A |
| FAM132A | Family sequence similarity 132, A | 18.0 | N/A |
| MB | Myoglobin | 14.3 | 12.4 |
| CRH | Corticotropin releasing hormone | 14.3 | 13.3 |
| PHGDH | Phosphoglycerate dehydrogenase | 11.6 | 5.4 |
| GC | Group Specific Component | −48.0 | N/A |
| PIT54 | PIT 54 protein precursor | −46.0 | N/A |
| FGA | Fibrinogen alpha chain | −20.8 | −3.0 |
| FGG | Fibrinogen gamma chain | −18.1 | −2.8 |
| OGCHI | Orosomucoid 1 | −16.9 | N/A |
| ALB | Albumin | −16.8 | −4.0 |
| ENSGAL00000016859 | Uncharacterized protein | −14.9 | N/A |
| FGB | Fibrinogen beta chain | −13.3 | −3.8 |
| APOH | Apolipoprotein H | −13.1 | N/A |
| YFV | MHC I antigen precursor | −12.9 | N/A |
This table provides a summary of both the top ten upregulated and downregulated genes found among affected chickens within the sample population. Positive and negative fold change values support, respectively, upregulation and downregulation of gene expression in affected birds relative to the gene expression in unaffected birds. The fold change for each gene is also presented along with the fold change for each gene that was tested using the NanoString nCounter® Technology to verify our expression data
Top biological functions of genes differentially expressed between Wooden Breast myopathy-affected and unaffected birds as presented by Ingenuity Pathway Analysis (IPA®)
| Biological Functions |
| # Molecules | |
|---|---|---|---|
| Diseases and disorders: | |||
| Cancer | 3.18E-31 – 4.08E-05 | 1208 | |
| Gastrointestinal Disease | 9.84E-26 – 3.06E-05 | 890 | |
| Cardiovascular Disease | 7.45E-21 – 4.06E-05 | 293 | |
| Hepatic System Disease | 1.86E-20 – 3.06E-05 | 593 | |
| Neurological Disease | 1.95E-17 – 3.92E-05 | 407 | |
| Molecular and Cellular Functions: | |||
| Cellular Assembly and Organization | 7.25E-19 – 1.14E-05 | 321 | |
| Cellular Function and Maintenance | 7.25E-19 – 2.06E-05 | 402 | |
| Cellular Movement | 1.80E-17 – 3.43E-05 | 322 | |
| Cell Morphology | 1.51E-16 – 2.53E-05 | 387 | |
| Cellular Growth and Proliferation | 2.81E-16 – 3.82E-05 | 476 | |
| Physiological System Development and Function: | |||
| Nervous System Development/Function | 9.74E-14 – 3.90E-05 | 195 | |
| Tissue Development | 9.74E-14 – 3.82E-05 | 501 | |
| Cardiovascular System Dev./Function | 2.75E-13 – 3.70E-05 | 237 | |
| Organismal Development | 5.44E-13 – 3.63E-05 | 432 | |
| Embryonic Development | 9.51E-13 – 3.10E-05 | 306 | |
| Top Canonical Pathways: | P-Value | Genes | Ratio |
| Hepatic Fibrosis/Stellate Cell Activation | 2.83E-12 | 43/197 | 0.218 |
| Epithelial Adherens Junction Signaling | 2.39E-08 | 30/146 | 0.205 |
| Actin Cytoskeleton Signaling | 3.18E-07 | 36/217 | 0.166 |
| Axonal Guidance Signaling | 1.27E-06 | 56/433 | 0.129 |
| Coagulation System | 1.39E-06 | 12/35 | 0.343 |
Top Biological Functions of DE genes associated with affected chickens from the sample population within this study provided by Ingenuity Pathway Analysis (IPA®). The P-value provided by this table was determined by IPA by comparing the number of genes found within each category (# of Genes) with the number of known genes within the IPA software system. The P-value for the “Top Canonical Pathways” is also determined by IPA in the same manner
Fig. 2The “Coagulation System” pathway highlighting differentially expressed genes in birds affected with Wooden Breast myopathy. Canonical pathways were identified and depicted by Ingenuity Pathway Analysis (IPA®) software. This pathway shows the “Coagulation System” as related to significant DE genes in affected birds from the sample population. Genes that are highlighted in green are considered to be downregulated in affected birds. Genes that are highlighted in red are considered to be upregulated in affected birds
Fig. 3The “Actin Cytoskeleton Signaling” pathway highlighting differentially expressed genes of birds affected with Wooden Breast myopathy. Canonical pathways were identified and depicted by Ingenuity Pathway Analysis (IPA®) software. This pathway shows the “Actin Cytoskeleton Signaling” as related to significant differentially expressed genes in affected birds from the sample population. Genes that are highlighted in green are considered to be downregulated in affected birds. Genes that are highlighted in red are considered to be upregulated in affected birds
Summary of main categories of genes involved in Wooden Breast myopathy separated by category
| Gene category | Gene name | Symbol | RNA-seq fold change | Nanostring fold change |
|---|---|---|---|---|
| Fiber-Type Switching: | ||||
| Myoglobin | MB | 14.3 | 12.4 | |
| Myosin Binding Protein C, slow type | MYBPC1 | 9.1 | 16.2 | |
| Myozenin 2 | MYOZ2 | 7.8 | 7.7 | |
| Troponin I type I, skeletal slow | TNNI1 | 4.0 | N/A | |
| Intracellular Calcium: | ||||
| ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 | ATP2A2 | 2.1 | N/A | |
| Cytosolic phospholipase A2 | PLA2G4A | 2.3 | N/A | |
| Parvalbumin | PVALB | 8.1 | 7.2 | |
| Phospholipase B1 | PLB1 | 3.4 | N/A | |
| Hypoxia: | ||||
| 6-phophofructo-2-kinase | PFKFB3 | −4.1 | N/A | |
| Arylhydrocarbon Receptor Nuclear Translocator 2 | ARNT2 | 2.2 | 1.7 | |
| Asparagine synthetase | ASNS | 4.4 | N/A | |
| Matrix metallopeptidase 2 | MMP2 | 2.2 | N/A | |
| Muscle-specific carbonic anhydrase III | CA3 | 28.5 | 25.5 | |
| Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | PLOD2 | 2.5 | N/A | |
| Transforming growth factor beta 3 | TGFB3 | 3.9 | 3.7 | |
| Transient receptor potential cation channel, subfamily A | TRPA1 | 6.7 | N/A | |
| Oxidative Stress: | ||||
| Corticotrophin-releasing hormone | CRH | 14.3 | 13.3 | |
| FK506 binding protein | FKBP51 | −1.9 | N/A | |
| Glutathione peroxidase 7 | GPX7 | 2.3 | N/A | |
| Glutathione peroxidase 8 | GPX8 | 2.1 | N/A | |
| Heat shock 27 kDa protein family, member 7 | HSPB7 | 3.2 | 4.3 | |
| Heat shock 70 kDa protein 4-like protein | HSPA4L | 1.5 | N/A | |
| Heat shock 105 kDa/110 kDa protein 1 | HSPH1 | 2.2 | N/A | |
| Heat shock transcription factor 2 | HSF2 | 2.9 | N/A | |
| Muscle-specific carbonic anhydrase III | CA3 | 28.5 | 25.5 | |
| Selenoprotein O | SELO | −2.1 | N/A | |
| Cellular Repair: | ||||
| ADAM metallopeptidase domain 12 | ADAM12 | 2.2 | N/A | |
| Cysteine and glycine-rich protein 3 | CSRP3 | 23.2 | 27.3 | |
| Epidermal growth factor | EGF | 1.6 | N/A | |
| Fibroblast growth factor 1 | FGF1 | −2.1 | −1.9 | |
| Fibroblast growth factor10 | FGF10 | 2.4 | 1.3 | |
| Musculoskeletal embryonic nuclear protein 1 | MUSTN1 | 4.9 | 6.0 | |
| Myosin, heavy chain 13, skeletal muscle | MYH13 | −4.7 | 1.0 | |
| Myosin, light chain 2, skeletal slow | MYL3 | 5.4 | 1.5 | |
| Myosin, light chain 12A regulatory | MYL12A | 1.9 | N/A | |
| Myosin light chain kinase 2 | MYLK2 | −2.6 | N/A | |
| Nephroblastoma Overexpressed | NOV | 7.3 | 3.0 | |
| Rho GTPase activating protein 10 | ARHGAP10 | 2.2 | N/A | |
| Rho GTPase activating protein 20 | ARHGAP20 | 2.4 | N/A | |
| Rho GTPase activating protein 40 | ARHGAP40 | 3.0 | 2.8 | |
| Rho-related BTB domain containing 3 | RHOBTB3 | −11.9 | −5.1 | |
| Sema domain, Ig, short basic domain, secreted, 3A | SEMA3A | 1.6 | N/A | |
For each gene category, the complete gene name, symbol, fold change from RNA-seq data, and fold change from Nanostring® data are provided. Positive and negative fold change values support respectively upregulation and downregulation of gene expression in birds affected by Wooden Breast myopathy relative to the gene expression in unaffected birds